Medtech Fundings for November 2013

Fundings for medical technology in November 2013 totaled $472 million, led by the $120 million IPO by Tandem Diabetes. Below is a list of the month’s top fundings:

Company funding Product/technology
Tandem Diabetes, Inc., has raised $120 million in an initial public offering according to the company Insulin pump, glucose monitoring and other diabetes products
Direct Flow Medical, Inc., has raised $50 million in a private round of funding from PDL BioPharma according to press reports Transcatheter aortic valve system used to treat aortic stenosis
TriVascular, Inc., has raised $40 million in a Series E round of funding according to the company Minimally invasive technologies for treatment of endovascular aneurysm
Solta Medical, Inc., has raised $40 million in a round of funding according to the company Medical aesthetics devices and other products
Palmaz Scientific has raised $26.31 million of a planned $30 million round of funding according to a regulatory filing Advanced metallurgical nanotechnologies for use in implants in neurology and orthopedics
Pixium Vision has raised €15 million ($20.27 million) in a Series A round of funding according to the company Retinal implants
Sensible Medical Innovations Ltd. has raised $20 million in a private funding from Boston Scientific Corporation according to the company Thoracic fluid status monitor

For the complete list of medtech fundings during November 2013, see link.

Published by

P. Driscoll

Patrick Driscoll founded MedMarket Diligence and has become a leading source of analysis and insight in medical technology markets. He previously co-founded Medtech Insight and was a principal at Medical Data International. He has 25 years of experience assessing current and potential markets for medical technologies.

Leave a Reply